Skip to main content
Erschienen in: International Urology and Nephrology 2/2018

03.01.2018 | Nephrology - Original Paper

Clinicopathological study of male and female patients with lupus nephritis: a retrospective study

verfasst von: Wei Peng, Yi Tang, Li Tan, Wei Qin

Erschienen in: International Urology and Nephrology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to assess the impact of sex on long-term outcomes in patients with lupus nephritis (LN).

Methods

Data of patients were collected at a single tertiary hospital from June 2010 to June 2016. Clinicopathological features and treatment responses of LN patients with different genders were compared. The primary endpoint was serum creatinine level doubled, GFR < 15 mL/min, initiation of renal replacement treatment or death. The secondary endpoint was complete remission or partial remission.

Results

In total, 101 male patients and 579 females were included. The follow-up time was 49.7 ± 15.2 months. In clinical data, photosensitivity and mouth ulcers were more common in the female patients, while males had more serositis and vasculitis. In laboratory data, males had higher values of blood pressure, hemoglobin, urine protein, serum creatinine and a lower level of serum albumin. Activity index and endocapillary hypercellularity scores in the male group were significantly increased. No sex disparity was identified across secondary endpoints in all cases, despite a lower ratio of CR in males. As for the long-term survival, no statistic difference between the two groups was observed. In a further multivariate Cox hazard analysis, male gender was not identified as an independent risk factor for poor outcomes.

Conclusion

Despite a greater disease activity and more severe organ damage in males with LN, we did not observe any significant gender disparity in long-term survival. Large multicenter collaborative efforts are necessary.
Literatur
1.
Zurück zum Zitat Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10(2):413–424PubMed Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10(2):413–424PubMed
2.
Zurück zum Zitat Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res 64(2):159–168. https://doi.org/10.1002/acr.20683 CrossRef Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res 64(2):159–168. https://​doi.​org/​10.​1002/​acr.​20683 CrossRef
3.
Zurück zum Zitat Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, Lopez-Longo FJ, Calvo-Alen J, Olive A, Fernandez-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narvaez FJ, Rosas J, Ibanez-Barcelo M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MA, Raya E, Diez-Alvarez E, Vazquez-Rodriguez T, Garcia de la Pena P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernandez-Cruz B, Marenco de la Fuente JL, Gantes M, Ucar E, Alegre-Sancho JJ, Manero J, Ibanez-Ruan J, Rodriguez-Gomez M, Quevedo V, Hernandez-Beriain J, Silva-Fernandez L, Alonso F, Perez S, Rua-Figueroa I (2016) Characterization of patients with lupus nephritis included in a large cohort from the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Medicine 95(9):e2891. https://doi.org/10.1097/md.0000000000002891 CrossRefPubMedPubMedCentral Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, Lopez-Longo FJ, Calvo-Alen J, Olive A, Fernandez-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narvaez FJ, Rosas J, Ibanez-Barcelo M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MA, Raya E, Diez-Alvarez E, Vazquez-Rodriguez T, Garcia de la Pena P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernandez-Cruz B, Marenco de la Fuente JL, Gantes M, Ucar E, Alegre-Sancho JJ, Manero J, Ibanez-Ruan J, Rodriguez-Gomez M, Quevedo V, Hernandez-Beriain J, Silva-Fernandez L, Alonso F, Perez S, Rua-Figueroa I (2016) Characterization of patients with lupus nephritis included in a large cohort from the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Medicine 95(9):e2891. https://​doi.​org/​10.​1097/​md.​0000000000002891​ CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A (2007) ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25(9):1751–1762. https://doi.org/10.1097/HJH.0b013e3282f0580f CrossRefPubMed Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A (2007) ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25(9):1751–1762. https://​doi.​org/​10.​1097/​HJH.​0b013e3282f0580f​ CrossRefPubMed
8.
Zurück zum Zitat Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291PubMed Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288–291PubMed
9.
Zurück zum Zitat Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241–250CrossRefPubMed Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241–250CrossRefPubMed
10.
Zurück zum Zitat Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75(3):382–391CrossRefPubMed Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75(3):382–391CrossRefPubMed
12.
Zurück zum Zitat Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 72(269):779–833PubMed Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 72(269):779–833PubMed
22.
Zurück zum Zitat Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M, Reveille JD, Alarcon GS, Vila LM, Reid J, Harris B, Li S, Kelly JA, Harley JB (2008) Klinefelter’s syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58(8):2511–2517. https://doi.org/10.1002/art.23701 CrossRefPubMedPubMedCentral Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M, Reveille JD, Alarcon GS, Vila LM, Reid J, Harris B, Li S, Kelly JA, Harley JB (2008) Klinefelter’s syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58(8):2511–2517. https://​doi.​org/​10.​1002/​art.​23701 CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Riveros Frutos A, Casas I, Rua-Figueroa I, Lopez-Longo FJ, Calvo-Alen J, Galindo M, Fernandez-Nebro A, Pego-Reigosa JM, Olive Marques A (2017) Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Lupus 26(7):698–706. https://doi.org/10.1177/0961203316673728 CrossRefPubMed Riveros Frutos A, Casas I, Rua-Figueroa I, Lopez-Longo FJ, Calvo-Alen J, Galindo M, Fernandez-Nebro A, Pego-Reigosa JM, Olive Marques A (2017) Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort. Lupus 26(7):698–706. https://​doi.​org/​10.​1177/​0961203316673728​ CrossRefPubMed
Metadaten
Titel
Clinicopathological study of male and female patients with lupus nephritis: a retrospective study
verfasst von
Wei Peng
Yi Tang
Li Tan
Wei Qin
Publikationsdatum
03.01.2018
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1780-y

Weitere Artikel der Ausgabe 2/2018

International Urology and Nephrology 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.